What's new? Log in Free sign up

Filing search / Petros Pharmaceuticals, Inc. / "Environment"

Search information

Petros Pharmaceuticals, Inc.

Companies

"Environment"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

37 results

Newest first Best match first

PTPI Petros Pharmaceuticals, Inc.

Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants

(i) are in compliance with all federal, state, local and foreign laws relating to pollution or protection of human health or the environment … ”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous

PTPI Petros Pharmaceuticals, Inc.

Prospectus supplement with pricing info

and strengthening the internal control environment will require a substantial effort, as necessary, and Petros will test the ongoing operating … and the creation of customized, virtual web-based environment tailored to the needs of our partners. Petros has an established industry-wide network

PTPI Petros Pharmaceuticals, Inc.

IPO registration (amended)

and strengthening the internal control environment will require a substantial effort, as necessary, and Petros will test the ongoing operating effectiveness … that are intended to stem primarily from licensing fees and the creation of customized, virtual web-based environment tailored to the needs of our partners

14 Feb 25

11:28am

PTPI Petros Pharmaceuticals, Inc.

IPO registration (amended)

or the environment (including ambient air, surface water, groundwater, land surface or subsurface strata), including laws relating to emissions, discharges … ”) into the environment, or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling

14 Feb 25

11:28am

PTPI Petros Pharmaceuticals, Inc.

IPO registration (amended)

control environment will require a substantial effort, as necessary, and Petros will test the ongoing operating effectiveness of the new and existing … , with primary revenue streams that are intended to stem primarily from licensing fees and the creation of customized, virtual web-based environment

13 Feb 25

9:42am

IPO registration (amended)

13 Feb 25

9:42am

IPO registration (amended)

10 Feb 25

5:01pm

hrn2p0prw pvjz4b9s3

IPO registration (amended)

10 Feb 25

5:01pm

IPO registration

24 Jan 25

5:02pm

1 Apr 24

4:31pm

u0dmcjv2wl892wni

Prospectus supplement

1hmp4vkrawd7y0z7q2t

Shelf registration (amended)

15 Sep 23

5:16pm

Shelf registration

11 Aug 23

4:31pm

spr1bgbpw6s wcs0t

Petros Pharmaceuticals Announces Capital Raise of $15 million

31 Mar 23

5:00pm

Prospectus update (post-effective amendment)

31 Mar 22

5:09pm

be5vmbg2pm eg8nn0fgr

Prospectus supplement

IPO registration

6 Jan 22

4:31pm

664c2wz6uqfxijqvvx

Petros Pharmaceuticals Announces $7.5 Million Offering

Prev
1
2
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.